Magnetic Resonance-Guided Prostate Biopsy.
The optimal strategy for prostate cancer diagnosis is to avoid overdiagnosis, defined as diagnosis of clinically insignificant disease, and undersampling of the gland, which leads to missing clinically significant disease. Targeted prostate biopsy is a potential solution for decreasing the rate of both overdiagnosis and undersampling of prostate cancer. We focus here on different techniques for targeting prostate lesions identified on multiparametric MR imaging and review different clinical settings in which MR imaging-targeted prostate biopsies are performed.
Department of Radiology, University of Minnesota, 420 Delaware Street, SE Minneapolis, MN 55455, USA.
S Saeid
SS
Dianat
The James Buchanan Brady Urological Institute, The Johns Hopkins University, 600 North Wolfe Street, Marburg 100, Baltimore, MD 21287, USA.
H Ballentine
HB
Carter
The Russell H. Morgan Department of Radiology and Radiological Science, The James Buchanan Brady Urological Institute, The Johns Hopkins University, 601 North Caroline Street, JHOC 3140C, Baltimore, MD 21287, USA. Electronic address: kmacura@jhmi.edu.
Katarzyna J
KJ
Macura
D006801:Humans; D061705:Image-Guided Biopsy / Q000379:methods*; D053783:Magnetic Resonance Imaging, Interventional / Q000379:methods*; D008297:Male; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000473:pathology*
MR imaging; Magnetic resonance-guided biopsy; Prostate biopsy; Prostate cancer; Targeted biopsy